Stay updated on APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial

Sign up to get notified when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T13:23:36.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page adds a new release note: Revision: v3.4.2. The administrative notice about government funding and operating status has been removed, along with a previous release note Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T02:12:51.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T23:59:51.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI updates include a glossary display option and updated policy/QC labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) with older labels removed. These changes do not affect the study details, eligibility criteria, or results.
    Difference
    0.2%
    Check dated 2026-01-28T00:16:30.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4. This is a minor version update and does not affect the study information or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-01-14T00:58:21.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing study sites by state (California, Florida, Iowa, Minnesota, North Carolina, Tennessee, Washington) and removed the prior per-state location headings.
    Difference
    0.8%
    Check dated 2025-12-23T10:25:35.000Z thumbnail image

Stay in the know with updates to APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 in wAIHA/CAD Safety, Efficacy Clinical Trial page.